Name: UMIN ID:
Unique ID issued by UMIN | UMIN000006669 |
---|---|
Receipt number | R000007876 |
Scientific Title | Discontinuation of adalimumab without functional and structural damage progression after attaining sustained remission in patients with rheumatoid arthritis: An observational study |
Date of disclosure of the study information | 2011/11/05 |
Last modified on | 2022/02/16 09:47:08 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2011/11/04 11:54:33 | ||
2 | Update | 2014/05/04 09:41:49 | TEL Last name of contact person Last name of contact person Address Address |
|
3 | Update | 2017/12/06 15:06:51 | UMIN ID1 |
|
4 | Update | 2017/12/08 15:12:20 | Last name of contact person Last name of contact person Name of primary person or sponsor Organization Category of Funding Organization Email1 |
|
5 | Update | 2017/12/08 15:14:47 | Recruitment status Other related information |
|
6 | Update | 2019/01/08 12:12:22 | Last follow-up date Date of closure to data entry Other related information Other related information |
|
7 | Update | 2020/05/27 14:30:14 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
8 | Update | 2022/02/16 09:47:08 | Recruitment status Date of IRB Date trial data considered complete Date analysis concluded |